+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coagulation & Hemostasis Testing Market by Product Type, Test Type, End User, Technology, Workflow - Global Forecast to 2030- Product Image
Coagulation & Hemostasis Testing Market by Product Type, Test Type, End User, Technology, Workflow - Global Forecast to 2030- Product Image
Sale

Coagulation & Hemostasis Testing Market by Product Type, Test Type, End User, Technology, Workflow - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5456914
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coagulation & Hemostasis Testing Market grew from USD 5.88 billion in 2024 to USD 6.56 billion in 2025. It is expected to continue growing at a CAGR of 11.31%, reaching USD 11.20 billion by 2030.

Setting the Stage for Advancement in Coagulation and Hemostasis Testing

Advancements in coagulation and hemostasis testing have reached a pivotal juncture where technological innovation, regulatory evolution, and shifting patient needs converge to redefine the future of diagnostic laboratories. Over the past decade, the imperative for rapid, precise, and cost-effective testing solutions has intensified, driven by rising prevalence of bleeding disorders, an aging population, and growing demand for personalized treatment regimens. Laboratories and healthcare providers now prioritize not only accuracy but also integration of data analytics, workflow automation, and connectivity within clinical networks. This introductory overview frames the key forces shaping market activity, highlighting the interplay between emerging assay platforms, digital transformation, and evolving quality standards. By establishing the current landscape, this section prepares decision-makers to appreciate the transformative shifts and strategic imperatives detailed in subsequent parts of the executive summary.

Emerging Disruptors Reshaping the Coagulation Testing Landscape

The coagulation and hemostasis testing space is undergoing fundamental disruption as novel assay methodologies, point-of-care connectivity, and artificial intelligence-driven analytics reshape both clinical and laboratory workflows. Microfluidics and optical detection platforms are converging with cloud-based data management to enable real-time diagnostic insights in decentralized settings. Meanwhile, immunoassay innovations and electrochemical detection techniques are expanding the scope of specialized tests-from genetic thrombophilia panels to high-sensitivity D-dimer assays-at previously unattainable throughput levels. Laboratories are integrating control materials, calibrators, and cuvette-based consumables into automated systems that streamline routine PT INR and APTT testing. At the same time, standalone analyzers and next-generation integrated systems are delivering scalable solutions that bridge diagnostic labs, hospital networks, and physician offices. This wave of transformative shifts is not confined to assay performance alone; it extends to embedded analytics solutions and LIMS modules that provide actionable patient risk profiles, predictive modeling, and decision support across the continuum of care.

Assessing the 2025 US Tariff Shake-Up on Coagulation Equipment

The cumulative impact of the United States’ 2025 tariff adjustments has introduced new cost dynamics across the procurement of instruments, reagents, and software used in coagulation and hemostasis testing. Imported integrated systems, point-of-care devices, and standalone analyzers now face increased duty burdens that have elevated landed costs for diagnostic laboratories. Manufacturers have responded by diversifying their supply chains, localizing reagent production for both lyophilized and ready-to-use formats, and negotiating stepped tariff exemptions for critical control materials and calibrators. These strategic adaptations have, in turn, influenced pricing frameworks for consumables such as cuvettes and control panels, as well as for analytics solutions and data management licenses. In parallel, some providers have accelerated investments in domestic manufacturing capabilities and partnerships with contract development organizations to mitigate volatility. Consequently, testing centers are recalibrating procurement strategies for routine APTT, fibrinogen, and PT INR assays, while specialized assays like D-dimer and genetic thrombophilia panels reflect regional cost differentials tied to tariff pass-through.

Unveiling Market Dynamics Through Deep Segmentation Insights

Dissecting the market by product type reveals distinct growth drivers and investment priorities for consumables, instruments, reagents, and software segments. Consumables-ranging from calibrators and control materials to cuvettes-remain the linchpin of high-volume laboratories, whereas integrated systems, point-of-care devices, and standalone analyzers command premium positioning by offering automation and rapid turnaround times. In the reagents domain, the balance between lyophilized kits and ready-to-use formulations reflects laboratory preferences for storage stability versus workflow efficiency. On the software side, analytics solutions, data management platforms, and LIMS modules are increasingly bundled with hardware to create end-to-end offerings. Meanwhile, examination of test type segmentation underscores robust adoption of routine assays such as APTT, fibrinogen, and PT INR, even as specialized tests like D-dimer quantification and thrombophilia panels-particularly genetic assays and immunoassays-gain traction for personalized risk assessment. End users spanning diagnostic labs, hospital labs, physician offices, and research institutes leverage electrochemical detection, immunoassays, microfluidics, and optical detection technologies to tailor workflows according to volume and complexity. Finally, the point-of-care versus laboratory-based workflow segmentation spotlights a strategic pivot toward decentralized testing, driven by demand for near-patient diagnostics that minimize turnaround time without sacrificing analytical rigor.

Regional Performance Patterns Defining Growth Trajectories

Across the Americas, sustained healthcare investment and a strong reimbursement environment underpin widespread adoption of advanced coagulation and hemostasis testing platforms. In contrast, Europe, the Middle East & Africa reveal a heterogeneous landscape where mature Western European markets prioritize integrated automation and data interoperability, while growth in emerging regions is fueled by public health initiatives and capacity building for specialized assays. The Asia-Pacific region exhibits the fastest uptake of point-of-care diagnostics, supported by robust government funding in hospital laboratories and expanding private diagnostic networks. Regulatory harmonization efforts across regional blocs are lowering barriers to cross-border technology transfer, further amplifying market penetration. These varied regional dynamics highlight the necessity for tailored market entry strategies, pricing models, and partnership approaches that reflect local infrastructure, reimbursement protocols, and clinician preferences.

Spotlight on Market Leaders Powering Innovation

Leading players are intensifying innovation and strategic alliances to maintain competitive edge in coagulation and hemostasis testing. Established multinational corporations continue to expand their portfolio of integrated systems, point-of-care devices, and standalone analyzers through targeted acquisitions and internal R&D investment. At the same time, specialized reagent and consumable manufacturers are forming collaborative agreements with data management and LIMS providers to deliver comprehensive workflow solutions. New entrants leveraging microfluidics, electrochemical detection, and cloud-native analytics are forcing incumbents to accelerate digitalization roadmaps. Partnerships between instrument OEMs and genetic assay developers are driving the next wave of personalized thrombophilia panels, while software vendors are offering modular architectures that integrate seamlessly with third-party analyzers. Collectively, these strategic moves are reshaping the competitive landscape, raising the bar for assay sensitivity, throughput, and patient-centric reporting across all end-user segments.

Strategic Actions to Navigate the Future of Coagulation Testing

Industry leaders should adopt a three-pronged approach to secure future growth: first, prioritize interoperability by embedding advanced analytics solutions and LIMS integration across assay platforms to streamline data flows and improve decision support. Second, diversify supply chains by forging localized manufacturing partnerships for reagents and consumables, thereby mitigating tariff exposure and ensuring continuity of supply. Third, accelerate adoption of microfluidics and point-of-care systems within outpatient and decentralized settings to capture new revenue streams and enhance patient engagement. Complementing these steps, companies must cultivate cross-functional collaboration between R&D, regulatory affairs, and commercial teams to expedite time-to-market for differentiated assays, such as genetic thrombophilia panels and high-sensitivity D-dimer tests. By executing these strategic imperatives, market participants will reinforce their competitive positioning and drive sustainable value creation in an increasingly dynamic environment.

Approach to Research and Data Validation for Market Clarity

This report synthesizes primary interviews with key opinion leaders, validated by quantitative surveys across laboratory directors, pathologists, and procurement managers. Secondary research encompasses a rigorous review of regulatory filings, clinical trial outcomes, and peer-reviewed publications to identify performance benchmarks and adoption barriers. Market dynamics were further refined through analysis of patent portfolios, company financial disclosures, and M&A activity, providing context for competitive positioning and technology roadmaps. Data triangulation techniques ensured consistency between supply-side insights and end-user demand patterns, while expert panels convened to evaluate emerging assay innovations and workflow integrations. Quality controls, including double-blind data audits and third-party vendor verification, were applied to uphold the integrity of findings. This methodological framework delivers comprehensive, balanced, and actionable intelligence for stakeholders seeking to navigate the complexities of the coagulation and hemostasis testing market.

Concluding Perspectives on Coagulation and Hemostasis Testing

As coagulation and hemostasis testing continues to evolve, stakeholders must remain vigilant of technological breakthroughs, regulatory shifts, and cost pressures that will define market trajectories. The interplay between routine and specialized assays, shifting reimbursement environments, and global supply chain realignments underscores the need for agile strategies. By leveraging the insights presented here-ranging from segmentation analyses to actionable recommendations-organizations can anticipate challenges, identify opportunities for differentiation, and align investment priorities with patient care imperatives. The journey ahead will demand collaboration across industry, healthcare providers, and policymaking bodies to deliver timely, accurate, and accessible diagnostics that improve clinical outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Consumables
      • Calibrators
      • Control Materials
      • Cuvettes
    • Instruments
      • Integrated Systems
      • Point Of Care Devices
      • Standalone Analyzers
    • Reagents
      • Lyophilized
      • Ready To Use
    • Software
      • Analytics Solutions
      • Data Management
      • LIMS
  • Test Type
    • Routine Tests
      • APTT
      • Fibrinogen
      • PT INR
    • Specialized Tests
      • D Dimer
      • Thrombophilia Panels
        • Genetic Assays
        • Immunoassays
  • End User
    • Diagnostic Labs
    • Hospital Labs
    • Physician Offices
    • Research Institutes
  • Technology
    • Electrochemical Detection
    • Immunoassays
    • Microfluidics
    • Optical Detection
  • Workflow
    • Laboratory Based
    • Point Of Care
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Sysmex Corporation
  • Instrumentation Laboratory Company
  • Diagnostica Stago SA
  • Ortho Clinical Diagnostics, Inc.
  • bioMérieux SA
  • Helena Laboratories, LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coagulation & Hemostasis Testing Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Calibrators
8.2.2. Control Materials
8.2.3. Cuvettes
8.3. Instruments
8.3.1. Integrated Systems
8.3.2. Point Of Care Devices
8.3.3. Standalone Analyzers
8.4. Reagents
8.4.1. Lyophilized
8.4.2. Ready To Use
8.5. Software
8.5.1. Analytics Solutions
8.5.2. Data Management
8.5.3. LIMS
9. Coagulation & Hemostasis Testing Market, by Test Type
9.1. Introduction
9.2. Routine Tests
9.2.1. APTT
9.2.2. Fibrinogen
9.2.3. PT INR
9.3. Specialized Tests
9.3.1. D Dimer
9.3.2. Thrombophilia Panels
9.3.2.1. Genetic Assays
9.3.2.2. Immunoassays
10. Coagulation & Hemostasis Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Labs
10.3. Hospital Labs
10.4. Physician Offices
10.5. Research Institutes
11. Coagulation & Hemostasis Testing Market, by Technology
11.1. Introduction
11.2. Electrochemical Detection
11.3. Immunoassays
11.4. Microfluidics
11.5. Optical Detection
12. Coagulation & Hemostasis Testing Market, by Workflow
12.1. Introduction
12.2. Laboratory Based
12.3. Point Of Care
13. Americas Coagulation & Hemostasis Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Coagulation & Hemostasis Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Coagulation & Hemostasis Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Siemens Healthineers AG
16.3.3. Abbott Laboratories
16.3.4. Danaher Corporation
16.3.5. Sysmex Corporation
16.3.6. Instrumentation Laboratory Company
16.3.7. Diagnostica Stago SA
16.3.8. Ortho Clinical Diagnostics, Inc.
16.3.9. bioMérieux SA
16.3.10. Helena Laboratories, LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. COAGULATION & HEMOSTASIS TESTING MARKET MULTI-CURRENCY
FIGURE 2. COAGULATION & HEMOSTASIS TESTING MARKET MULTI-LANGUAGE
FIGURE 3. COAGULATION & HEMOSTASIS TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. COAGULATION & HEMOSTASIS TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. COAGULATION & HEMOSTASIS TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COAGULATION & HEMOSTASIS TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CALIBRATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CUVETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY POINT OF CARE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STANDALONE ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY READY TO USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ANALYTICS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY LIMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY APTT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PT INR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY D DIMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY GENETIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ELECTROCHEMICAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY OPTICAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 80. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 81. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 82. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 83. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 85. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 86. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 87. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 151. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 157. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 163. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 165. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 168. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 187. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 189. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 190. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 191. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 192. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 193. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 194. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 195. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 196. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 199. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 201. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 202. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 247. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 249. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 250. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 252. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 271. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 273. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 274. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 275. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 276. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 277. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 278. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 279. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 280. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 283. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 285. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 287. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 288. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 289. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 291. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 292. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ROUTINE TESTS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY SPECIALIZED TESTS, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY THROMBOPHILIA PANELS, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN COAGULATION & HEMOSTA

Companies Mentioned

The companies profiled in this Coagulation & Hemostasis Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Danaher Corporation
  • Sysmex Corporation
  • Instrumentation Laboratory Company
  • Diagnostica Stago SA
  • Ortho Clinical Diagnostics, Inc.
  • bioMérieux SA
  • Helena Laboratories, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.2 Billion
Compound Annual Growth Rate11.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030 - Product Image

Hemostasis Diagnostics Market by Product, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Hemostasis Diagnostic Devices and Equipment Market Report 2025 - Product Image

Hemostasis Diagnostic Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Hemostasis Diagnostic Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Hemostasis Diagnostic Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 153 Pages
  • Global
From
Hemostasis Diagnostics - Global Strategic Business Report - Product Image

Hemostasis Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (POC Testing Systems, Consumables), By Test (Prothrombin Time Test, D Dimer Test), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (POC Testing Systems, Consumables), By Test (Prothrombin Time Test, D Dimer Test), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.